Kaposi's Sarcoma

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease

A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma

Optical Biopsy of Human Skin in Conjunction With Laser Treatment

Risk Factors for Non-HIV-Related Kaposi s Sarcoma

Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions

Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma

BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma

Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma

124I-FIAU Imaging in EBV and KSHV Associated Cancers

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients

Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers

Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT

Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma

Spectroscopy With Surface Coils and Decoupling

Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity

Anti-Retrovirals for Kaposi's Sarcoma

HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT